Intel (INTC) stock jumped 6% after announcing a $14.2B deal to buy back Apollo’s stake in its Ireland chip plant, signaling improved financial health.
Browsing: News
Sandisk surged 168% in Q1 2025 for its best quarter ever while AppLovin fell 44.78%. Complete breakdown of S&P 500 tech stock winners and losers.
March ADP jobs report reveals 62,000 private-sector positions added, exceeding Wall Street’s 38,500 forecast. Small businesses and healthcare led growth.
Iran’s IRGC threatens Apple (AAPL), Microsoft (MSFT), Nvidia (NVDA), Google (GOOGL) and 14 other tech companies with attacks from April 1 over Middle East operations.
NASA’s Artemis II moon mission launches with 4 astronauts. Space stocks like Rocket Lab surge. SpaceX valued at $1.3T eyes record $75B IPO.
DeFi Technologies (DEFT) stock soared 32% after reporting FY25 revenue of $99.1M, up 215% YoY, with net income reaching $62.7M from a prior-year loss.
Firefly Aerospace (FLY) shares jumped 20.5% Tuesday on SpaceX IPO news. Revenue surged 541% YoY to $57.67M. Wall Street targets $35.13 price.
Oracle (ORCL) stock jumped 6% after announcing layoffs of up to 30,000 workers to fund AI data center expansion and improve cash flow.
Baidu (BIDU) stock drops as 100+ Apollo Go robotaxis freeze mid-traffic in Wuhan due to system failure, trapping riders for hours.
CoinShares (CSHR) debuts on Nasdaq after $1.2B SPAC merger with Vine Hill Capital. The European crypto manager oversees $6B across 39 investment funds.
OpenAI completes historic $122B funding round at $852B valuation, led by Amazon, Nvidia, and SoftBank, with 900M weekly ChatGPT users and $2B monthly revenue.
NIO (NIO) stock jumped 9% after reporting March deliveries of 35,486 vehicles, up 136% YoY, with Q1 totals reaching 83,465 units, up 98.3%.
RH (RH) stock declined after disappointing Q4 earnings and revenue miss, with tariffs impacting margins and Q1 2026 revenue expected to fall 2%-4%.
Goldman Sachs believes the stock market’s recent decline has created favorable conditions for April, with Q1 earnings season now taking center stage.
Cyclerion Therapeutics (CYCN) soars 160% after unveiling reverse merger with Korsana Biosciences and $380M private placement for Alzheimer’s drug development.